Literature DB >> 9560066

Prognostic factors in very old demented adults: a seven-year follow-up from a population-based survey in Stockholm.

H Agüero-Torres1, L Fratiglioni, Z Guo, M Viitanen, B Winblad.   

Abstract

OBJECTIVE: To detect prognostic factors in very old demented subjects with Alzheimer's disease (AD), vascular dementia (VaD), and other types of dementia (OD).
DESIGN: Follow-up clinical examinations of dementia patients from a population-based study after 3- and 7-year intervals. SETTING AND PARTICIPANTS: In an established population aged 75 years and older in Stockholm, Sweden, there were 133 cases of AD, 52 of VaD, and 38 of OD. MAIN OUTCOME MEASURES: Predictors of survival at 3- and 7-year follow-up examinations were evaluated by Cox proportional hazard models. Progression was measured as the annual rate of change in Mini-Mental State Examination (MMSE) scores. Linear models were used to evaluate predictors of progression.
RESULTS: Older age, male gender, low education, comorbidity, and functional disability predicted shorter 7-year survival in the 223 prevalent dementia cases. Other factors, including type of dementia, dementia severity, and duration of the disease were not significant. The average rate of cognitive decline in the 81 mild to moderate demented subjects who survived 3 years was 2.4 MMSE points per year. Type of dementia (AD vs OD), higher baseline cognitive function, and greater functional disability predicted faster decline. Despite similar survival probability, predictors of death varied as a function of dementia type: Older age (for AD and VaD), comorbidity (for AD and OD), and functional dependency (for VaD). In AD, prognostic factors were similar to those described for the combined dementia groups, with the exception of an accelerated cognitive decline among women.
CONCLUSIONS: Although methodological difficulties exist, it is possible to identify demented subjects with worse prognoses (shorter survival and faster cognitive decline) by using clinical and demographic data. Clinicians and healthcare planners should be aware of the potential usefulness of functional dependence as a prognostic indicator. Finally, the need for careful clinical examinations of demented subjects is stressed by the increased mortality found among those demented who are also affected by other chronic conditions.

Entities:  

Mesh:

Year:  1998        PMID: 9560066     DOI: 10.1111/j.1532-5415.1998.tb02464.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  34 in total

1.  Predictors of mortality in patients with Alzheimer's disease living in nursing homes.

Authors:  G Gambassi; F Landi; K L Lapane; A Sgadari; V Mor; R Bernabei
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-07       Impact factor: 10.154

2.  Latent classes of course in Alzheimer's disease and predictors: the Cache County Dementia Progression Study.

Authors:  Jeannie-Marie S Leoutsakos; Sarah N Forrester; Christopher D Corcoran; Maria C Norton; Peter V Rabins; Martin I Steinberg; Joann T Tschanz; Constantine G Lyketsos
Journal:  Int J Geriatr Psychiatry       Date:  2014-11-03       Impact factor: 3.485

3.  Diagnosis, risk factors, and treatment of vascular dementia.

Authors:  Oscar L Lopez; Lewis H Kuller; James T Becker
Journal:  Curr Neurol Neurosci Rep       Date:  2004-09       Impact factor: 5.081

4.  Effects of Food and Drug Administration-approved medications for Alzheimer's disease on clinical progression.

Authors:  Michelle M Mielke; Jeannie-Marie Leoutsakos; Chris D Corcoran; Robert C Green; Maria C Norton; Kathleen A Welsh-Bohmer; JoAnn T Tschanz; Constantine G Lyketsos
Journal:  Alzheimers Dement       Date:  2012-02-01       Impact factor: 21.566

5.  Repetition priming and change in functional ability in older persons without dementia.

Authors:  Debra A Fleischman; Julia L Bienias; David A Bennett
Journal:  Neuropsychology       Date:  2009-01       Impact factor: 3.295

6.  Caregiver-recipient closeness and symptom progression in Alzheimer disease. The Cache County Dementia Progression Study.

Authors:  Maria C Norton; Kathleen W Piercy; Peter V Rabins; Robert C Green; John C S Breitner; Truls Ostbye; Christopher Corcoran; Kathleen A Welsh-Bohmer; Constantine G Lyketsos; Joann T Tschanz
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2009-06-29       Impact factor: 4.077

7.  Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study.

Authors:  JoAnn T Tschanz; Chris D Corcoran; Sarah Schwartz; Katherine Treiber; Robert C Green; Maria C Norton; Michelle M Mielke; Kathleen Piercy; Martin Steinberg; Peter V Rabins; Jeanne-Marie Leoutsakos; Kathleen A Welsh-Bohmer; John C S Breitner; Constantine G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2011-06       Impact factor: 4.105

8.  The effects of commonly prescribed drugs in patients with Alzheimer's disease on the rate of deterioration.

Authors:  J Ellul; N Archer; C M L Foy; M Poppe; H Boothby; H Nicholas; R G Brown; S Lovestone
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-09-29       Impact factor: 10.154

9.  The Cache County Study on Memory in Aging: factors affecting risk of Alzheimer's disease and its progression after onset.

Authors:  Joann T Tschanz; Maria C Norton; Peter P Zandi; Constantine G Lyketsos
Journal:  Int Rev Psychiatry       Date:  2013-12

Review 10.  The Potential of Gonadal Hormone Signalling Pathways as Therapeutics for Dementia.

Authors:  X Du; R A Hill
Journal:  J Mol Neurosci       Date:  2016-08-15       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.